News & Events
Knome Closes $13 Million Financing Round
CAMBRIDGE, MA – January 10, 2014 – Knome, Inc. announced that it has successfully closed a $13 Million financing round led by current investors. The funds will be used to promote growth and expansion of its genomic services and software systems businesses. Since 2007,...
Omixon and Knome Partner to Offer Advanced HLA Typing for Whole Genome and Exome Level Data
CAMBRIDGE, MA — June 3, 2013 — Knome Inc., the human genome interpretation company, today announced that its Services division will now provide its clients with advanced HLA typing capabilities as part of its whole genome and exome interpretation offerings. These...
Knome’s knoSYS™100 Featured in the New York Times
An excerpt of an interesting article featuring Knome… The price of sequencing a person’s genome — putting in order all three billion base pairs of DNA in a set of human chromosomes — keeps dropping. But interpreting the billions of letters in a person’s DNA...
2012: The Year When Genomic Medicine Started Paying Off
An excerpt of an interesting article mentioning Knome [emphasis ours]… Remember a couple of years ago when people commemorated the 10-year anniversary of the first draft human genome sequencing? The storyline then, in 200, was that we all went off to genome...
Direct-to-Consumer Genomics Reinvents Itself
An excerpt of an interesting article mentioning Knome [emphasis ours]: Cambridge, Massachusetts–based Knome made one of the splashiest entries into the field, but has now turned entirely to contract research. The company began providing DTC whole-genome...
George Church on The Colbert Report
Watch our co-founder George Church on The Colbert Report promoting his book Regenesis: How Synthetic Biology Will Reinvent Nature and Ourselves.
A Bloomberg Terminal For DNA Sequencing
Forbes staff, Matthew Herper, compares the knoSYS to a Bloomberg terminal in an article on October 1, 2012. An excerpt: [The knoSYS] is essentially a realization that sometimes experts want particular types of data a few steps away, putting the DNA analysis...
Knome Appoints Heidi L. Rehm, PhD to Scientific Advisory Board
Dr. Rehm brings deep experience in clinical genomics and patient care as Knome continues to expand CAMBRIDGE, MA – July 9, 2012 – Knome Inc., the human genome interpretation company, announced today that a leading clinical geneticist, Heidi Rehm, PhD, has...
Ready or Not, Genomics is Coming to a Hospital Near You
Luke Timmerman reports on the leap genomics has taken from academic research and big pharma to patient care in hospitals and clinics and how Knome is responding to this new demand. Excerpt: Like Foundation Medicine, Knome is also seeing demand grow from...
Knome Selected as a Genome Interpretation Partner for Illumina Genome Network
Firms partner to offer Illumina’s high-quality genome sequencing services in combination with Knome’s advanced genome interpretation solutions CAMBRIDGE, MA – April 3, 2012 – Knome Inc., the human genome interpretation company, announced today that it has been...